FMP
Apr 2, 2025 2:22 PM - Davit Kirakosyan
Meta's Smart Glasses Ambitions Could Reshape Its Future; BofA Reiterates Buy
Bank of America is maintaining a Buy rating and $765 price target on Meta Platforms (NASDAQ:META) as the company reportedly gears up to introduce a new line of premium smart glasses—a potential game-changer for its hardware strategy. The upcoming device, codenamed Hypernova, is expected to launch by...
Apr 2, 2025 2:19 PM - Davit Kirakosyan
Truist Upgrades Scotts Miracle-Gro to Buy, Shares Gain 4%
Scotts Miracle-Gro (NYSE:SMG) shares rose around 4% intra-day today after Truist Securities upgraded the company from Hold to Buy, maintaining a $70 price target, as the firm sees the stock offering compelling value amid a stabilizing lawn and garden market. Analysts believe that the U.S. lawn and g...
Apr 2, 2025 2:17 PM - Davit Kirakosyan
Clear Street Starts Coverage on MicroStrategy with Buy Rating, Sees Unique Bitcoin Upside
Clear Street initiated coverage on MicroStrategy (NASDAQ:MSTR) with a Buy rating and a $422 price target, highlighting the company’s distinct approach to leveraged Bitcoin exposure as a key differentiator from traditional crypto investment vehicles like ETFs. Unlike passive instruments, MicroStrateg...
Apr 2, 2025 2:15 PM - Davit Kirakosyan
UBS Sees Upside for Ulta Beauty as Market Pressures Ease
UBS maintained its Buy rating and $490 price target on Ulta Beauty (NASDAQ:ULTA), citing signs of stabilization in the retailer’s market position and improved conditions across several key areas. Analysts pointed to recent data suggesting that Ulta’s market share has leveled off, indicating a potent...
Apr 2, 2025 2:12 PM - Davit Kirakosyan
TD Cowen Downgrades ESS Tech to Hold, Stock Drops 6%
ESS Tech (NYSE:GWH) shares dropped more than 6% intra-day today after TD Cowen downgraded the company from Buy to Hold, with analysts slashing the price target from $10 to $3, citing mounting challenges tied to leadership changes, funding concerns, and extended timelines for profitability. While ack...
Apr 2, 2025 1:49 PM - Davit Kirakosyan
UBS Downgrades Reinsurance Group of America to Neutral on Execution Risks and Fully Priced Growth Outlook
UBS downgraded Reinsurance Group of America (NYSE:RGA) from Buy to Neutral, setting a price target of $216. The downgrade reflects growing concerns that short-term upside may be limited, even as the company aggressively pursues long-term growth. While UBS acknowledges that RGA’s management is target...
Apr 1, 2025 12:58 PM - Davit Kirakosyan
TD Cowen Maintains Buy on Johnson & Johnson Despite Talc Settlement Setback
TD Cowen reaffirmed its Buy rating and $185 price target on Johnson & Johnson (NYSE:JNJ) following news that a federal judge rejected the company's latest bankruptcy-based proposal to settle its talc-related lawsuits, which pushed the stock price down more than 5% intra-day today. According to the r...
Apr 1, 2025 12:55 PM - Davit Kirakosyan
Jefferies Stays Bullish on Trip.com, Citing Strong Travel Trends and AI Upside
Jefferies reaffirmed its Buy rating and $77 price target on Trip.com Group (NASDAQ:TCOM), expressing confidence in the company’s ability to deliver on expectations for the current quarter and beyond. Jefferies sees robust domestic demand driving growth in hotel bookings and air ticketing, with volum...
Apr 1, 2025 12:52 PM - Davit Kirakosyan
Kroger Downgraded to Sell as Walmart Reclaims Grocery Dominance
Melius Research downgraded Kroger (NYSE:KR) to Sell, assigning a $58 price target, citing a sharp erosion in the grocery chain’s competitive edge as Walmart reasserts itself as the dominant force in U.S. grocery retail. Analysts reflected on a period from 2013 to 2015 when Kroger nearly rivaled Walm...
Apr 1, 2025 12:47 PM - Davit Kirakosyan
UBS Maintains Neutral on Apple as iPhone Sales Weaken in Key Markets
UBS reiterated its Neutral rating and $236 price target on Apple (NASDAQ:AAPL), noting that iPhone sell-through trends turned negative year-over-year in February, particularly in China and Europe, where the company continues to lose market share. According to UBS’ review of Counterpoint data, global...
